LIVER-TARGETED INHIBITION OF PAPD5 AND PAPD7 LEADS TO
SUSTAINABLE HBsAg REDUCTION IN THE AAV-HBV MOUSE MODEL
|
|
| AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
XueZhou2, YoujunYu2, AnaïsLopez1, Josephine Felber1, Helene Gylling3, Gitte Friis3, LykkePedersen3, SørenOttosen3, Anna-Maria Geretti1and Henrik Mueller1
1Roche Innovation Center Basel, Basel, Switzerland; 2. Roche Innovation Center Shanghai, Shanghai, China; 3. Roche Innovation Center Copenhagen, Hørsholm, Denmark 
|
|
|  | |
|
|